fda warning letters compounded semaglutide tirzepatide september 2025 Sends to More Than 50 GLP-1 Compounders and Manufacturers Compounded weight loss injections —

Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency

Prioritize quality sleep to help your mind recharge, stay well-hydrated to maintain focus and mental energy, and take regular breaks from screens to reset and protect your attention span

The Medicare GLP-1 Bridge is a short-term CMS demonstration providing eligible Part D beneficiaries with access to certain GLP-1 drugs for obesity at a flat $50 monthly copay, running July 1, 2026 through December 31, 2027

Last Published 04.01.2026 Effective Date: 04.01.2026 This policy addresses deep brain stimulation and responsive cortical stimulation